In vitro wounding of airway smooth muscle cell monolayers increases expression of TGF-β receptors

Respiratory Physiology and Neurobiology

Volumn 132, Issue 3, 2002, Pages 341-346

  Chen, Gang ^a   Khalil, Nasreen ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Bronchi, epithelial cell injury; Disease, asthma; Mammals, cow; Mediators, TGF 1; Receptor, TGF ; Smooth muscle, airways; Upper airways, epithelial cell injury

Indexed keywords

COLLAGEN TYPE 1; CORTICOSTEROID; DEXAMETHASONE; FIBRONECTIN; RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTHMA; BREATHING MUSCLE; CATTLE; CELL DAMAGE; CONTROLLED STUDY; FIBROSIS; FLOW CYTOMETRY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING; WOUND;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; ANTI-INFLAMMATORY AGENTS; CATTLE; CELLS, CULTURED; COLLAGEN; DEXAMETHASONE; FIBRONECTINS; FLOW CYTOMETRY; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; STRESS, MECHANICAL; TRACHEA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0037019775     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9048(02)00111-8     Document Type: Article

References (10)

1. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., Vignola A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161:2000;1720-1745.
2. Chan M.T., Leung D.Y., Szefler S.J., Spain J.D. Difficult-to-control asthma: clinical characteristics of steroid insensitive asthma. J. Allergy Clin. Immunol. 101:1998;594-601.
3. Coutts A., Chen G., Stephens N., Hirst S., Douglas D., Eichholtz T., Khalil N. Release of biologically active TGF-β from airway smooth muscle cells induces autocrine synthesis of collagen. Am. J. Physiol. Cell Mol. Physiol. 280:2001;L999-L1008.
4. Gold L.I., Sung J.J., Siebert J.W., Longaker M.T. Type I (RI) and type II (RII) receptors for transforming growth factor-beta ligands during excisional wound repair. Am. J. Pathol. 150:1997;209-222.
5. Khalil N. Post translational activation of latent transforming growth factor β (L-TGF-beta): clinical implications. Histol. Histopath. 16:2001;541-551.
6. Khalil N., Parekh T.V., O'Connor R.N., Gold L.I. Differential expression of transforming growth factor-β type I and type II receptors by pulmonary cells in bleomycin-induced lung injury: correlation with repair and fibrosis. Exp. Lung Res. 27:2002;233-250.
7. McKay S., Sharma H.S. Autocrine regulation of asthmatic airway inflammation: role of airway smooth muscle. Resp. Res. 3:2002;11-23.
8. Morishima Y., Nomura A., Uchida Y., Noguchi Y., Sakamoto T., Ishii Y., Goto Y., Masuyama K., Zhang M.J., Hirano K., Mochizuki M., Ohtsuka M., Sekizawa K. Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding. Am. J. Respir. Cell Mol. Biol. 24:2001;1-11.
9. Powell D.W., Mifflin R.C., Valentich J.D., Crowe S.E., Saada J.S., West A.B. Myofibroblasts. I. Paracine cells important in health and disease. Am. J. Physiol. 277:1999;C1-C9.
10. Smith J.D., Bryant S.R., Couper L.L., Vary C.P.H., Getwals P.J., Koteliansky V.E., Lindner V. Soluble transforming growth factor-β type II receptor inhibits negative remodeling, fibroblast transdifferentiation and intimal lesion formation but not endothelial growth. Circ. Res. 84:1999;1212-1222.